These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9840679)
1. Islet expression of perforin, Fas/Apo-1 and interleukin-1 converting enzyme (ICE) in non-obese diabetic (NOD) mice. Ingelsson E; Saldeen J; Welsh N Immunol Lett; 1998 Oct; 63(3):125-9. PubMed ID: 9840679 [TBL] [Abstract][Full Text] [Related]
2. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes. Redd S; Ginn S; Ross JM Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794 [TBL] [Abstract][Full Text] [Related]
3. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets. Suarez-Pinzon W; Sorensen O; Bleackley RC; Elliott JF; Rajotte RV; Rabinovitch A Diabetes; 1999 Jan; 48(1):21-8. PubMed ID: 9892218 [TBL] [Abstract][Full Text] [Related]
4. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules. Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317 [TBL] [Abstract][Full Text] [Related]
5. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice. Augstein P; Heinke P; Salzsieder E; Berg S; Rettig R; Salzsieder C; Harrison LC Endocrinology; 2004 Jun; 145(6):2747-52. PubMed ID: 15033908 [TBL] [Abstract][Full Text] [Related]
6. Fas and Fas ligand immunoexpression in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes. Reddy S; Ross JM Ann N Y Acad Sci; 2003 Nov; 1005():166-9. PubMed ID: 14679052 [TBL] [Abstract][Full Text] [Related]
7. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent. Thomas HE; Darwiche R; Corbett JA; Kay TW J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene. Silva DG; Petrovsky N; Socha L; Slattery R; Gatenby P; Charlton B J Immunol; 2003 May; 170(10):4996-5002. PubMed ID: 12734343 [TBL] [Abstract][Full Text] [Related]
9. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas. Augstein P; Bahr J; Wachlin G; Heinke P; Berg S; Salzsieder E; Harrison LC J Autoimmun; 2004 Dec; 23(4):301-9. PubMed ID: 15571924 [TBL] [Abstract][Full Text] [Related]
10. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375 [TBL] [Abstract][Full Text] [Related]
11. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus. Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373 [TBL] [Abstract][Full Text] [Related]
12. Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes. Nakayama M; Nagata M; Yasuda H; Arisawa K; Kotani R; Yamada K; Chowdhury SA; Chakrabarty S; Jin ZZ; Yagita H; Yokono K; Kasuga M Diabetes; 2002 May; 51(5):1391-7. PubMed ID: 11978635 [TBL] [Abstract][Full Text] [Related]
13. Surface and intracellular Fas expression associated with cytokine-induced apoptosis in rodent islet and insulinoma cells. Augstein P; Wachlin G; Berg S; Bahr J; Salzsieder C; Hehmke B; Heinke P; Salzsieder E J Mol Endocrinol; 2003 Apr; 30(2):163-71. PubMed ID: 12683940 [TBL] [Abstract][Full Text] [Related]
14. The role of Fas ligand in beta cell destruction in autoimmune diabetes of NOD mice. Petrovsky N; Silva D; Socha L; Slattery R; Charlton B Ann N Y Acad Sci; 2002 Apr; 958():204-8. PubMed ID: 12021107 [TBL] [Abstract][Full Text] [Related]
15. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Yoon JW; Jun HS Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511 [TBL] [Abstract][Full Text] [Related]
16. Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice. Amrani A; Verdaguer J; Anderson B; Utsugi T; Bou S; Santamaria P J Clin Invest; 1999 Apr; 103(8):1201-9. PubMed ID: 10207172 [TBL] [Abstract][Full Text] [Related]
17. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation. Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779 [TBL] [Abstract][Full Text] [Related]
18. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704 [TBL] [Abstract][Full Text] [Related]
19. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus. Moriwaki M; Itoh N; Miyagawa J; Yamamoto K; Imagawa A; Yamagata K; Iwahashi H; Nakajima H; Namba M; Nagata S; Hanafusa T; Matsuzawa Y Diabetologia; 1999 Nov; 42(11):1332-40. PubMed ID: 10550417 [TBL] [Abstract][Full Text] [Related]
20. Transgenic expression of dominant-negative Fas-associated death domain protein in beta cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice. Allison J; Thomas HE; Catterall T; Kay TW; Strasser A J Immunol; 2005 Jul; 175(1):293-301. PubMed ID: 15972661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]